Suchergebnisse - "Chen, Jingde"

PubPharm (64)

1

JAK3/STAT5 signaling-triggered upregulation of PIK3CD contributes to gastric carcinoma development

enthalten in: Journal of cell communication and signaling | 2024

von Hu, Q. | Dou, N. | Wu, Q. | +3

2

JAK3/STAT5 signaling‐triggered upregulation of PIK3CD contributes to gastric carcinoma development

enthalten in: Journal of Cell Communication and Signaling | 2024

von Hu, Q. | Dou, N. | Wu, Q. | +3

3

China special issue on gastrointestinal tumors-Cetuximab retreatment plus camrelizumab and liposomal irinotecan in patients with RAS wild-type metastatic colorectal cancer : Cohort B of the phase II CRACK study

enthalten in: International journal of cancer | 2023

von Quan, M. | Chen, J. | Chen, Z. | +7

4

High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma

enthalten in: BMC cancer | 2023

von Xiu, M. | Bao, W. | Wang, J. | +3

5

PIAS3 promotes ferroptosis by regulating TXNIP via TGF-β signaling pathway in hepatocellular carcinoma

enthalten in: Pharmacological research | 2023

von Bao, W. | Wang, J. | Fan, K. | +2

6

Suppressed Voltage Deficit and Degradation of Perovskite Solar Cells by Regulating the Mineralization of Lead Iodide

enthalten in: Small (Weinheim an der Bergstrasse, Germany) | 2023

von Chen, L. | Chen, J. | Wang, C. | +6

7

TGF-β Signaling Activation Confers Anlotinib Resistance in Gastric Cancer

enthalten in: Pharmaceutical research | 2023

von Chen, J. | Hai, Y. | Hu, Q. | +3

8

YTHDF2 exerts tumor-suppressor roles in gastric cancer via up-regulating PPP2CA independently of m6A modification

enthalten in: Biological procedures online | 2023

von Zhou, Y. | Fan, K. | Dou, N. | +5

9

YTHDF2 exerts tumor-suppressor roles in gastric cancer via up-regulating PPP2CA independently of $ m^{6} $A modification

enthalten in: Biological procedures online | 2023

von Zhou, Y. | Fan, K. | Dou, N. | +5

10

China special issue on gastrointestinal tumors‐Cetuximab retreatment plus camrelizumab and liposomal irinotecan in patients with RAS wild‐type metastatic colorectal cancer : Cohort B of the phase II CRACK study

enthalten in: International Journal of Cancer | 2023

von Quan, M. | Chen, J. | Chen, Z. | +7

1
2
3
4
5
6
7
Nächster »
[7]